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ABSTRACT
Objective: To evaluate the implications of body mass index (BMI) in pregnancies complicated with
gestational diabetes (GD).
Study Design: Retrospective assessment of pregnancies complicated with GD managed at our
institution from January 2000 to December 2004.
Results: Obstetrical complications beyond GD occurred in: group A (BMI 20-24,9) - 23%; group B (BMI
25-29,9) - 18.8% and group C (BMI>30) - 35.3%, including hypertensive disorders in A-1.65%, B-3.76%
and C-9.6%. Mean value of HbA1c at third trimester was A-5.05, B-5.25 e C-5.41%. Insulin treatment was
needed in A 26.1%, B-41% and C-50.6%, and was started on average at A-32.8, B-30.5 and C-29.3
gestational weeks. Delivery occurred on average at 38 weeks in the three groups, with caesarean rates
of A-26.7%, B-33.1% and C-38.5%. Mean birthweight of the newborns was A-3189g, B-3307g and C-
3469g. There were 5 perinatal deaths (A-1, B-2 and C-2). Maternal and neonatal morbidity were not
significantly different in the three groups.
Conclusions: Obese pregnant women with GD had a higher mean maternal age, higher rates of
obstetrical complications (hypertensive in particular), higher levels of HbA1c in the third trimester,
needed insulin treatment more frequently and at earlier gestational ages, and their newborns were
heavier.
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INTRODUCTION
Obesity became a public health problem with growing
rates in industrialized countries, and affecting anyone
from women to men at all ages and social conditions.
The negative impact on the health of the affected
individuals is well known, as it elevates the risk for the
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development of cardiovascular diseases and diabetes,
among others.
In pregnant women (non diabetic), obesity is known
to increase the risk of obstetrical complications and
adverse perinatal results, such as a higher risk for
gestational diabetes, hypertensive complications,
infections, macrossomy, fetal death and distocic
deliveries.1,2
From clinical practice, there is the idea that obese
pregnant women, whose pregnancy is complicated with
gestational diabetes, have more difficulties in controlling
glycemic levels, with implications on the outcome of
the gestation.
With the present work, we aim to evaluate the
implications of body mass index (BMI) in pregnancies
complicated with Gestational Diabetes (GD).
POPULATION AND METHODS
A retrospective assessment was made of all singleton
pregnancies complicated with GD managed at our
institution from January 2000 to December 2004.
Gestational Diabetes was defined by criteria of our
National Screening. In women with no risk factors for
development of diabetes, the O’Sullivan test is done
by the 24th and 32nd weeks of gestation. If the test is
positive (glycaemia >140 mg/dl one hour after ingestion
of 50 g of glucose in 200 ml of water), an oral glucose
tolerance test (OGTT – glycaemia at 0, 60, 120 and
180 minutes after ingestion of 100 g of glucose in 400
ml of water) is undertaken. GD diagnose is made if
two or more of these glycaemia measures are greater
than the values of 95, 180, 155 and 140, respectively.
When pregnant women have risk factors for
development of GD, the O’Sullivan test is also made
at the first visit.
Those pregnant women were divided in 3 groups
according to the Body Mass Index (BMI): A- normal
weight (BMI 20-24.9 Kg/m2), B – overweight (BMI
25-29.9 Kg/m2) and C – obese (BMI e”30 Kg/m2).
The BMI was calculated upon the prepregnant
weight at the first prenatal visit.
Women with multiple pregnancies and with a BMI
<20 Kg/m2 or unknown were excluded from this
study.
In each group were analysed the following variables:
maternal age, weight gain, family history of diabetes,
previous GD, stillbirth and macrossomy, obstetrical
complications, gestational age at GD diagnose,
glicosilated haemoglobin (HbA1c), insulin need and
gestational age of introduction, gestational age at delivery,
type of delivery, birthweight, newborn malformations,
perinatal mortality, perinatal and maternal morbidity and
admission to Newborn Intensive Care Unit (NICU).
The statistical analysis was made by ANOVA test
for quantitative variables and by the Mann-Whitney
test for qualitative variables.
A p value <0.05 was considered significant.
RESULTS
Of the 698 pregnancies included, 303 (43.4%) were
integrated in group A (BMI 20-24,9 Kg/m2), 239
(34.2%) in group B (BMI 25-29,9 Kg/m2) and 156
(22.3%) in group C (BMI >30 Kg/m2). Tables I, II
and III summarize the results.
The obese group (C) had a significantly  higher (p=01)
mean maternal age - 32,8 years, when compared to group
A - 31,4 years, as well as to group B – 32.4 years, (p=0.03).
Weight gain was significantly lower (p<.001) in
group C - 6,9 Kg, in relation to group A - 10,4 Kg.
Regarding family history of diabetes - 49,5% vs
53,9% vs 54,5% -, previous gestational diabetes - 5,9%
vs 10,1% vs 12,2% - and stillbirth - 2,6% vs 4,6% vs
2,5% -, there were no significantly differences between
the 3 groups. Previous macrossomy was higher, (p<.001),
in group C - 13,9% - comparatively to group A - 4,1%.
Obstetrical complications (including preterm birth,
preterm rupture of membranes and infections) occurred
in higher rates (p=.006) in group C (35.3%) when
compared to group A (23,1%), and also when
compared (p=.0001) to group B (18,8%). Hypertensive
disorders, in particular, were more frequent in group C
(9,6%) and in group B (3,8%) comparatively to group
A (1,6%), although statistic significance only occurred
between groups A and C (p=.0001).
Gestational diabetes diagnosis was made signifi-
cantly earlier in group C – 27,2 weeks - (p <.0001)
and in group B – 28,5 weeks - (p =.04) when compared
to group A – 29,8 weeks.
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Mean value of HbA1c at third trimester was
significantly (p<.0001) higher in group C (5,4%) and
in group B (5,2%), when compared to group A (5,0%).
Insulin treatment was needed in 50.6% of group
C and in 41.1% of group B, while in just 26% of
group A, these differences being statistically
significant (p=.0001). It was started on average at
Table I Results from the study and statistic evaluation between Groups A – normal weight women, and B – overweight pregnant
women
Group A Group B p value
N (n) 303 239 -
Mean Maternal Age (years) 31.4 32.4 0.03
Mean GA at diagnose  (weeks) 29.8 28.5 0.04
Hypertensive disorders (%) 1.6 3.8 n.s.
Insulin need (%) 26 41.1 0.000
Mean GA at insulin start (weeks) 32.8 30.5 0.03
HbA1c 3rd trimester (%) 5.0 5.2 0.00
Mean GA at delivery (weeks) 38.4 38.5 n.s.
Caesarean rate (%) 26.7 33.1 n.s.
Mean birthweight (g) 3189 3307 0.03
Macrossomy (%) 9.2 19.7 0.001
Neonatal morbidity (%) 7.6 8.4 n.s.
NICU admission (%) 4 3.8 n.s.
Perinatal mortality (%) 0.1 0.3 n.s.
*a p value <.05 was considered significant
Table II   Results from the study and statistic evaluation between Groups A – normal weight women, and C – obese
pregnant women
Group A Group C p value
N (n) 303 156 -
Mean Maternal Age (years) 31.4 32.8 0.01
Mean GA at diagnose  (weeks) 29.8 27.2 0.000
Hypertensive disorders (%) 1.6 9.6 0.000
Insulin need (%) 26 50.6 0.000
Mean GA at insulin start (weeks) 32.8 29.3 0.001
HbA1c 3rd trimester (%) 5.0 5.4 0.000
Mean GA at delivery (weeks) 38.4 38.4 n.s.
Caesarean rate (%) 26.7 38.5 0.008
Mean birthweight (g) 3189 3469 0.000
Macrossomy (%) 9.2 30.2 0.000
Neonatal morbidity (%) 7.6 12.2 n.s.
NICU admission (%) 4 7.1 n.s.
Perinatal mortality (%) 0.1 0.3 n.s.
* a p value < .05 was considered significant
29,3 gestational weeks in group C, at 30.5 in group B
and  at 32,8  in group A, this differences being
statistically significant with p=.001 and p=.03,
respectively.
Delivery occurred on average at 38 weeks in the
3 groups, with caesarean rates higher in group C -
38,5%, in relation to group A - 26,7%, (p =.008).
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The newborns of group A were lighter (3189g) when
compared to those of group C (3469g, p<.0001), but
also when compared to group B (3307g, p=.009).
Admissions to NICU and perinatal deaths were not
different in the studied groups, as well as the neonatal
malformation rates and maternal and neonatal
morbidity.
In relation to pregnant women with normal weight,
obese pregnant women with GD had a higher mean
maternal age, higher rates of obstetrical complications
(hypertensive in particular), earlier diagnose of GD,
higher levels of HbA1c at the 3rd trimester, needed
insulin treatment more frequently and at earlier
gestational ages. They also had higher rates of
caesarean deliveries and their newborns were heavier,
with higher rates of macrossomy.
Overweight pregnant women with gestational
diabetes (when compared to the normal weight group),
had a higher maternal age, lower mean gestational age
at diagnosis and at insulin start, needed insulin more
frequently and had higher values of HbA1c in the 3rd
trimester. Their newborns were heavier and also with
higher rates of macrossomy.
Regarding the differences between overweight and
obese pregnant women, we found that the last group
had higher levels of hypertensive disorders, higher
levels of HbA1c in the 3rd trimester and their newborns
were heavier (also with higher rates of macrossomy).
DISCUSSION
Although there are a large number of studies regarding
pregnancy outcomes according to pre-pregnancy
weight in non-diabetic women, there are only a few
studies regarding pregnancy outcomes and glycemic
level controls in those complicated with gestational
diabetes1. Nevertheless, in these studies an association
between overweight and obesity with bad metabolic
control and higher rates of pregnancy complications is
reported.
Since obesity itself is a risk factor for adverse
pregnancy outcomes, one of the purposes of prenatal
visits, once the diagnosis of gestational diabetes is made,
is to obtain the best glycemic control possible1-3.
We found that obese women had more difficulties
in achieving the ideal glycemic control, needing more
frequently insulin treatment than other women, and at
earlier gestational ages. A favourable evolution in a
GD patient is dependent on the glycemic levels and on
the need to control them with insulin. In those pregnant
women that maintain euglycemic levels until delivery,
the risk of complications is not increased when
Table III  Results from the study and statistic evaluation between Groups B – overweight women, and C – obese pregnant women
Group B Group C p value
N (n) 239 156 -
Mean Maternal Age (years) 32.4 32.8 n.s.
Mean GA at diagnose  (weeks) 28.5 27.2 n.s.
Hypertensive disorders (%) 3.8 9.6 0.000
Insulin need (%) 41.1 50.6 n.s.
Mean GA at insulin start (weeks) 30.5 29.3 n.s.
HbA1c 3rd trimester (%) 5.2 5.4 0.01
Mean GA at delivery (weeks) 38.5 38.4 n.s.
Caesarean rate (%) 33.1 38.5 n.s.
Mean birthweight (g) 3307 3469 0.009
Macrossomy (%) 19.7 30.2 0.02
Neonatal morbidity (%) 8.4 12.2 n.s.
NICU admission (%) 3.8 7.1 n.s.
Perinatal mortality (%) 0.3 0.3 n.s.
* a p value < .05 was considered significant
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compared to non-diabetic women2] But this euglycemic
state is more difficult to obtain when GD women are
overweight or obese.
Pregnancy complications, including infections,
preterm rupture of membranes and preterm birth, were
also more frequent in the obese group, probably
reflecting the influence of obesity associated with a
deficient metabolic control. Hypertensive disorders,
which were also more frequent in this group, probably
reflect the ‘metabolic syndrome’. It is known that
obesity and gestational diabetes course frequently with
insulin resistance and hiperinsulinemia, which are also
common findings along with dyslipidemia and
hypertension1,2.
These difficulties in glycemic control did not affect
gestational age at delivery, but could be responsible
for the higher rates of caesarean and heavier newborns
in the obese women group.
These results reinforce the importance of health
education at the primary care level regarding the
benefits of losing weight, practicing exercise and
following an adequate diet, to minimise the adverse
complications that overweight can bring, especially in
those women who still are in a fertile age. And once
pregnant, they should be alerted for the crucial
importance of adequate weight gain control.
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